|
159
|
361
|
6vjcA |
Lmfpps mutant t164y in complex with 476a, ipp & ca |
|
156
|
361
|
6w7iA |
Lmfpps mutant t164w in complex with 476a, ipp & ca |
|
153
|
362
|
6ww1A |
Crystal structure of the lmfpps mutant e97y |
|
119
|
340
|
6n7zF |
Crystal structure of human fpps in complex with an allosteric inhibitor yf-02037 |
|
129
|
341
|
6n7yF |
Crystal structure of human fpps in complex with an allosteric inhibitor mit-01-102 |
|
130
|
344
|
6oahF |
Crystal structure of human fpps in complex with an allosteric inhibitor yf-02-78 |
|
131
|
344
|
6n83F |
Crystal structure of human fpps in complex with an allosteric inhibitor yf-02037 |
|
135
|
343
|
6n82F |
Crystal structure of human fpps in complex with an allosteric inhibitor yf-02037 |
|
102
|
292
|
6g31A |
Crystal structure of human geranylgeranyl diphosphate synthase mutant d188y bound to zoledronate |
|
108
|
292
|
6g32A |
Crystal structure of human geranylgeranyl diphosphate synthase mutant d188y |
|
132
|
343
|
5ksxF |
Crystal structure of human fpps in complex with an allosteric inhibitor am-02-072 |
|
123
|
341
|
5jv2F |
Crystal structure of human fpps in complex with an allosteric inhibitor mit-01-055 |
|
123
|
341
|
5juzF |
Crystal structure of human fpps in complex with an allosteric inhibitor cl-06-057 |
|
131
|
343
|
5jv0F |
Crystal structure of human fpps in complex with an allosteric inhibitor cl-08-038 |
|
125
|
342
|
5jv1F |
Crystal structure of human fpps in complex with an allosteric inhibitor cl-08-066 |
|
114
|
299
|
6c56A |
Crystal structure of mutant human geranylgeranyl pyrophosphate synthase (y246d) in its apo form |
|
106
|
298
|
6c57A |
Crystal structure of mutant human geranylgeranyl pyrophosphate synthase (y246d) in complex with bisphosphonate inhibitor fv0109 |
|
132
|
342
|
5ygiA |
Crystal structure of human fpps in complex with an inhibitor thz93 |
|
143
|
343
|
5cg5A |
Neutron crystal structure of human farnesyl pyrophosphate synthase in complex with risedronate |
|
138
|
343
|
5cg6A |
Neutron crystal structure of human farnesyl pyrophosphate synthase in complex with risedronate and isopentenyl pyrophosphate |
|
138
|
346
|
4demF |
Crystal structure of human fpps in complex with ys_04_70 |
|
136
|
343
|
3ryeA |
Human fdps synthase in complex with a n-methyl pyridinum bisphosphonate |
|
135
|
342
|
3s4jA |
Human fdps synthase in complex with a rigid analog of risedronate |
|
124
|
291
|
2q80A |
Crystal structure of human geranylgeranyl pyrophosphate synthase bound to ggpp |
|
131
|
340
|
5ja0F |
Crystal structure of human fpps with allosterically bound fpp |
|
120
|
318
|
5h9dA |
Crystal structure of heptaprenyl diphosphate synthase from staphylococcus aureus |
|
111
|
301
|
5e8hA |
Crystal structure of geranylfarnesyl pyrophosphate synthases 2 from arabidopsis thaliana |
|
105
|
297
|
5e8kA |
Crystal structure of polyprenyl pyrophosphate synthase 2 from arabidopsis thaliana |
|
100
|
298
|
5e8lA |
Crystal structure of geranylgeranyl pyrophosphate synthase 11 from arabidopsis thaliana |
|
132
|
343
|
5dgsF |
Crystal structure of human fpps in complex with the monophosphonate compound 15 |
|
134
|
345
|
5diqF |
Crystal structure of human fpps in complex with salicylic acid derivative 3a |
|
127
|
343
|
5djpF |
Crystal structure of human fpps in complex with biaryl compound 5 |
|
125
|
343
|
5djvF |
Crystal structure of human fpps in complex with biaryl compound 8e |
|
135
|
342
|
5djrF |
Crystal structure of human fpps in complex with biaryl compound 6 |
|
132
|
343
|
5dgmF |
Crystal structure of human fpps in complex with monophosphonate compound 7 |
|
132
|
343
|
5dgnF |
Crystal structure of human fpps in complex with compound 13 |
|
130
|
339
|
4xqtF |
Crystal structure of human fpps in complex with three magnesium ions |
|
129
|
341
|
4xqrF |
Crystal structure of unliganded human fpps at 2.15 angstrom resolution |
|
124
|
339
|
4xqsF |
Crystal structure of human fpps in complex with one magnesium ion |
|
123
|
339
|
4rxaA |
Crystal structure of human farnesyl diphosphate synthase in complex with bph-1358 |
|
133
|
342
|
4qpfA |
New lower bone affinity bisphosphonate drug design for effective use in diseases characterized by abnormal bone resorption |
|
134
|
341
|
4qxsF |
Crystal structure of human fpps in complex with wc01088 |
|
134
|
343
|
4pvxF |
Crystal structure of human fpps in complex with [({4-[4-(cyclopropyloxy)phenyl]pyridin-2-yl}amino)methanediyl]bis(phosphonic acid) |
|
136
|
341
|
4q23A |
The role of threonine 201 and tyrosine 204 in the human farnesyl pyrophosphate synthase catalytic mechanism and the mode of inhibition by the nitrogen-containing bisphosphonates |
|
120
|
339
|
4p0xA |
Human farnesyl diphosphate synthase in complex with taxodione |
|
137
|
346
|
4p0vA |
Crystal structure of human farnesyl diphosphoate synthase in complex with zoledronate and taxodione |
|
140
|
346
|
4pvyF |
Crystal structure of human fpps in complex with [({5-[4-(propan-2-yloxy)phenyl]pyridin-3-yl}amino)methanediyl]bis(phosphonic acid) |
|
134
|
346
|
4p0wA |
Human farnesyl diphosphate synthase in complex with arenarone and zoledronate |
|
138
|
342
|
4nkeA |
The effects of lysine 200 and phenylalanine 239 farnesyl pyrophosphate synthase (fpps) mutations on the catalytic activity, crystal structure and inhibition by nitrogen containing bisphosphonates |
|
137
|
346
|
4nfiF |
Crystal structure of human fpps in complex with magnesium and jds05120 |
